Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Identifying drugs needing pharmacogenetic monitoring in a Korean hospital.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists - 15 Jan 2007

Kim Young Mi, Yoo Seung Hee, Kang Rae Young, Kim Min Jung, Bae Yoon Young, Lee Yeon Kyung, Jeon Su Jin, Chon Kung Ju, Shin Sang Mi, Kim Sang Geon, Park Kyoung Ho, Son In Ja

Abstract excerpt

PURPOSE: A decision matrix for identifying drugs for which pharmacogenetic drug monitoring (PDM) provides the greatest benefit in a Korean setting is described. SUMMARY: We developed a decision matrix including the ethnic frequency of clinically relevant polymorphic cytochrome P-450 (CYP) enzymes...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cytochrome P-450 Enzyme System
Share to Decision Making

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Monitoring

Share to Drug-Related Side Effects and Adverse Reactions

Share to Hospitals

Share to Pharmaceutical Preparations

Share to Pharmacogenetics

Source

Identifiers

PMID: 17215467
DOI: 10.2146/ajhp050490

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-17215467-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Identifying drugs needing pharmacogenetic monitoring in a Korean hospital.PMID 17215467Read ↗

Cytochrome P450 2C19 enzyme, Cytochrome P450 2C9 enzyme, and Cytochrome P450 2D6 enzyme allelic variants and its possible effect on drug metabolism: A retrospective study.Semantic proximity Read ↗

[CYP2D6-, CYP2C9- and CYP2C19-based dose adjustments: when do they make sense?].Semantic proximity Read ↗

Functional pharmacogenetics/genomics of human cytochromes P450 involved in drug biotransformation.Semantic proximity Read ↗

Clinical Utility and Economic Impact of CYP2D6 Genotyping.Semantic proximity Read ↗

Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC) for CYP2C9 and Nonsteroidal Anti-Inflammatory Drugs.Semantic proximity Read ↗

Study on genetic polymorphisms and phenotypic frequency distribution of CYP2C9, CYP2C19 and CYP2D6 in Han Chinese populationSemantic proximity Read ↗

Meta-analysis of probability estimates of worldwide variation of CYP2D6 and CYP2C19.Semantic proximity Read ↗

Pharmacogenetics: Using Genetic Information to Guide Drug Therapy.Semantic proximity Read ↗

Pharmacotherapy Associated with CYP2C19, CYP2C9, CYP2D6, and UGT1A1 Genes in Population Sample: Observational Cross Sectional Analytical StudySemantic proximity Read ↗

The potential of CYP2D6 phenotyping to improve opioid dosing strategiesSemantic proximity Read ↗

The effect of cytochrome P450 metabolism on drug response, interactions, and adverse effects.Semantic proximity Read ↗

A Study on CYP2C19 and CYP2D6 Polymorphic Effects on Pharmacokinetics and Pharmacodynamics of Amitriptyline in Healthy Koreans.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.